Respiratory Syncytial Virus Infection: Developing Antiviral Drugs for Prophylaxis and Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 11, 2017
April 11, 2024
59a11b52-4b6d-43c3-a5e2-4d57eedf16bc
Related Documents
Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentNovember 1, 2019Center for Drug Evaluation and Research
Stimulant Use Disorders: Developing Drugs for Treatment
Guidance DocumentOctober 5, 2023Center for Drug Evaluation and Research
Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentOctober 26, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.